Osteocyte-derived extracellular vesicles
Osteocyte-derived extracellular vesicles has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, May 4, 2022: “The Protective Effects of Osteocyte-Derived Extracellular Vesicles Against Alzheimer's Disease Diminished with Aging”.
1 paper studies it2 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Funders: China Postdoctoral Science Foundation and 5 more
- Animals1
What did studies of Osteocyte-derived extracellular vesicles find?
2Studies of Osteocyte-derived extracellular vesicles measured 2 outcomes; the most studied are Alzheimer's disease (1 study) and cognitive impairment (1).
Alzheimer's disease
downin mice1
1 study
Alzheimer's disease
downin mice1
Osteocyte-derived extracellular vesicles decrease Alzheimer's disease in mice.
“ameliorate cognitive impairment and the pathogenesis of AD in APP/PS1 mice and model cells”
Animalsin APP/PS1 mice and model cells
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Cognitive impairment
downin mice1
1 study
Cognitive impairment
downin mice1
Osteocyte-derived extracellular vesicles decrease cognitive impairment in mice.
“young osteocyte, the most abundant cells in bone, secretes extracellular vesicles (OCYYoung -EVs) to ameliorate cognitive impairment”
Animalsin APP/PS1 mice
Advanced science (Weinheim, Baden-Wurttemberg, Germany)